Case-control study of the effect of HMG-CoA reductases on subarachnoid hemorrhage

Case-control study of the effect of HMG-CoA reductases on subarachnoid hemorrhage - SAH-Statin Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005963

Enrollment

400

Registered

2011-07-11

Start date

2009-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subarachnoid hemorrhage due to ruptured cerebral aneurysm and unruptured cerebral aneurysm

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases are patients who suffer from subarachnoid hemorrhage due to ruptured cerebral aneurysms. Controls are patients who have unruptured cerebral aneurysms.

Exclusion criteria

Exclusion criteria: Cerebral aneurysms due to trauma, dissection, infection, autoimmune diseases, hereditary diseases are excluded.

Design outcomes

Primary

Measure	Time frame
Information of cerebral aneurysms and intake of HMG-CoA reductases	—

Secondary

Measure	Time frame
Other clinical information including drug intake other than HMG-CoA reductases	—

Countries

Japan

Contacts

Public ContactKazuhiko Nozaki

Shiga University of Medical Science Neurosurgery

noz@belle.shiga.med.ac.jp077-548-2257

Outcome results